Theme 6: Breast pathology Flashcards

1
Q

What is screening?

A

the process of identifying people who appear healthy but may be at an increased risk of a disease or condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who is eligible for breast screening and how often are they screened?

A
  • Eligible women: 50-up to 71st birthday (age extension 47-73 in some areas)
  • invited every 3 years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does a breast screen consist of?

A
  • Clinical examination
  • Mammograms (2 X-rays of each breast) or USS
  • Biopsy - corecut or FNAC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How might a patient present with breast cancer?

A
  • a lump or thickening in the breast
  • a change in the nipple - morphology, rash, blood or fluid
  • a change in how the breast feels or looks
  • pain or discomfort in the breast or armpit
  • swelling or lump in the armpit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is FNAC?

A

Fine needle aspiration cytology - only undertaken for cystic lesions or used when a biopsy is contra-indicated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How are breast lumps graded in triple assessment?

A

Clinical - P1-P5
Radiology - R1-R5
Pathology - B1-B5

P1-normal
P2 - benign lesion
P3 - atypical
P4 - atypical, probably malignant 
P5 - malignant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is a mammogram looking for?

A

calcification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the procedure (i.e next steps) for each grades on biopsy (e.g B1-B5)

A

B1 –> return to screening
B2 –> reassure, return to screening
B3 –> uncertain malignant potential = excision
B4 –> suspicion of malignancy = rebiopsy or excision
B5 –> surgical excision (WLE or mastectomy)
B5a - DCIS
B5b - invasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is DCIS?

A

Ductal carcinoma in situ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the anatomical differences in male and female breasts?

A
  • no lobules
  • no TDLU’s
  • no cooper’s ligaments
  • no fibroadenomas
  • no cysts (arising from breast stroma)
  • can occasionally get breast carcinomas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are breast lobes drained by?

A

a lactiferous duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do all lobes converge towards?

A

areola

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a breast?

A
  • breast is a modified sweat gland composed of lobes and lobules of glands within fibroadipose stroma
  • composed of specialised epithelium and stroma
  • ductules drain into intralobular duct, which moves out to become the extralobular duct, which all converge to form the interlobular duct
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What disorders can arise from the terminal duct lobular units (TDLUs) ?

A
  • cysts
  • sclerosing adenosis
  • small duct papilloma
  • hyperplasia
  • atypical hyperplasia
  • carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What disorders can arise from the lobular stroma?

A
  • fibroadenoma

- phyllodes tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What disorders can arise from the large ducts and lactiferous sinuses?

A
  • duct ectasia
  • recurrent subareolar abscess
  • solitary ductal papilloma
  • pagets disease
17
Q

What disorders can arise from the interlobular stroma?

A
  • fat necrosis
  • lipoma
  • fibrous tumour
  • fibromatosis
  • sarcoma
18
Q

Is a fibroadenoma benign or malignant?

A

benign

19
Q

What is the most common breast disorder of the nipple

A

Pagets –> arises from large ducts

20
Q

What is fibrocystic change?

A
  • affects women 20-45 years of age
  • usually bilateral and multifocal
  • no increase risk for subsequent carcinoma development
21
Q

What is fibrocystic disease?

A

a constellation of benign, hormonally mediated breast changes which include cyst formation, stromal fibrosis and mild epithelial hyperplasia without atypia

22
Q

How might a patient with fibrocystic disease present?

A

lumpy, pre menstrually painful breasts

symptoms generally cease 1-2yrs after menopause

23
Q

Who is at risk of fibroadenoma?

A
  • incidence - common
  • usually in women 20-30 years
  • more common in afro-caribbean women
24
Q

What are the signs of fibroadenoma?

A

mobile, painless, well-defined breast lump

25
Q

What is the treatment of fibroadenoma?

A

surgical excision, some may recur

26
Q

What is a prevalent screen and what is an incident screen?

A

prevalent screen - first visit
incident screen
incident screen - not first visit

27
Q

What is DCIS?

A
  • ductal carcinoma in situ
  • malignant clonal proliferation of cells within breast parenchymal structures
  • a precursor of invasive carcinoma (pure DCIS cannot produce a metastasis but has the potential to progress to invasion if left)
28
Q

Explain how we grade breast cancer

A

T-tubule formation (1-3)
N-nuclear pleomorphism (1-3)
M-mitosis (1-3)

29
Q

Would a grade 1 tumour be well or poorly differentiated?

A

well differentiated

30
Q

What is breast cancer

A

a common cancer that arises anywhere in breast parencyma or accessory breast tissue

31
Q

What are the risk factors associated with breast cancer?

A
  • oestrogen
  • early menarche
  • late menopause
  • obesity in post menopausal women
  • OCPs
  • hormone therapy for menopause
  • alcohol
32
Q

What should a pathology report of a malignant breast cancer show?

A
  • in situ or invasive?
  • what type of tumour?
  • grade?
  • size?
  • evidence of vascular invasion?
  • nodal status?
  • relationship of tumour wrt margins?
  • molecular marker status: ER, PR, HER2
33
Q

What is the most common breast cancer?

A

invasive ductal carcinoma

34
Q

What are the important prognostic indicators when it comes to diagnosing breast cancer?

A
1. grading
the higher the grade, the higher the chance of recurrence 
2. vascular invasion 
3. nottingham prognostic index (NPI)
4. Margins
35
Q

Name some hormone targeted therapies for breast cancer

A

tamoxifen
aromatase inhibitors
bisphosphonates
her-2 targeted approach –> trastuzumab

36
Q

How is the molecular classsification of breast cancer decided?

A

classified into luminal A or B based on their ER and Her2 positivity